Synergistic molecular mechanisms in hormone-sensitive breast cancer.
Cussac
Antonio Llombart
AL
Medical Oncology Service, Hospital Universitario Arnau de Vilanova, Lleida, Spain.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D019008:Drug Resistance, Neoplasm / Q000502:physiology; D004357:Drug Synergism; D006728:Hormones / Q000378:metabolism; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000378:metabolism; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D015398:Signal Transduction / Q000187:drug effects* / Q000502:physiology
D000970:Antineoplastic Agents; D006728:Hormones; D036341:Intercellular Signaling Peptides and Proteins; D047428:Protein Kinase Inhibitors